Anadrol vs Kisspeptin
FDA Approved vs Emerging
synergistic Mechanism-based · 49% Kisspeptin helps manage estrogen conversion from Anadrol. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.
Molecular Data
Anadrol Kisspeptin
Weight 332.48 Da 1,213.42 Da (KP-10) / 6,087 Da (KP-54)
Half-life ~8-9 hours ~4 minutes (KP-10), ~28-32 minutes (KP-54)
Chain — 10-54 amino acids
Type 17-alpha alkylated anabolic steroid (C21H32O3) Neuropeptide family (RFamide)
Key Benefits
Anadrol
01 Rapid and dramatic increases in muscle mass and bodyweight
02 Exceptional strength gains, often noticeable within the first week
03 Potent stimulation of erythropoietin and red blood cell production
04 Increased appetite and nutrient partitioning in some users
05 Improved recovery between training sessions
06 Full, round muscle appearance due to intramuscular water and glycogen retention
07 FDA-approved treatment for various forms of anemia
Kisspeptin
01 Potent reproductive hormone stimulation (LH/FSH)
02 Restoration of natural testosterone production
03 Fertility enhancement
04 Sexual function support
05 Hypogonadism treatment potential
Dosing Protocols
Anadrol
25-50 mg/day / Once or twice daily (oral)
Kisspeptin
100-200 mcg per injection / Single dose for testing, or 2-3 times weekly (NEVER daily - causes desensitization)
Gonadotropin stimulation 100-200mcg Single dose or 2-3x weekly
Fertility support 0.4-1.0 nmol/kg (50-150mcg) As directed by physician
Sexual function (clinical) 1 nmol/kg/h 75-minute IV infusion
Side Effects
Anadrol
Significant water retention and bloating (estrogenic, not aromatase-mediated)
Elevated blood pressure (fluid volume and RBC increase)
Severe liver stress and elevated liver enzymes (AST/ALT)
Back pumps and lower back pain during exercise
Headaches (often blood pressure-related)
Appetite suppression (paradoxical for a mass-building compound)
Lethargy and fatigue (hepatic strain-related)
Acne and oily skin
Suppression of natural testosterone production
Kisspeptin
Minimal acute side effects reported
Potential mild cardiovascular effects
Contraindications
Pre-existing liver disease or significantly elevated liver enzymes
Prostate cancer or breast cancer in males
Nephrotic phase of nephritis
Hypercalcemia (Anadrol can exacerbate calcium levels)
Pregnancy (Category X - causes virilization of the female fetus)
Known hypersensitivity to oxymetholone
Concurrent use of other 17-alpha alkylated oral steroids (compounded liver toxicity)
Not recommended during pregnancy or breastfeeding
Caution with cardiovascular disease history
Daily dosing causes receptor desensitization
Research Evidence
Anadrol Kisspeptin
Status FDA Approved Emerging
References 5 studies 4 studies
Latest 2018 2025
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.